Natera To Support New Clinical Trial Assessing ctDNA Dynamics With Latitude in Advanced Skin Cancers
NTRA•Natera to support new clinical trial
- Natera, Inc. NTRA.O said it will support a new clinical trial assessing ctDNA dynamics with Latitude™ in advanced skin cancers.
- The trial will assess ctDNA dynamics in advanced skin cancer patients using Latitude MRD testing.
Source text: ID:nBw5V3G7ra
Further company coverage: NTRA.O
